Skip to content

DeepRhythm Platform

by Medicalgorithmics S.A.

510(k) K232161

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK232161 Date20 Jun 2024ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
20 Jul 2023
FDA decision
20 Jun 2024 (Substantially Equivalent)
FDA review time
336 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K232161 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K232161 decided 20 Jun 2024 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
DPS
Device class
Class II
Regulation
21 CFR Part 870.2340
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The DeepRhythm Platform is a hardware-agnostic cloud-based software system designed for the detection, classification, and analysis of electrocardiogram (ECG) data using deep learning algorithms. It leverages advanced AI techniques, including convolutional neural networks and transformer models, to identify and assess cardiac arrhythmias with high diagnostic precision.

This platform is supplied as a cloud-based solution, intended for use in clinical settings by healthcare professionals for remote monitoring and automated ECG analysis. It is classified under the product code DPS and has received FDA 510(k) clearance and MDR authorization. The system is not single-use but is designed for repeated use within a regulated healthcare environment, with no specific sterility or MRI safety requirements stated.

Devices cleared under K232161

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K232161
UDI-DISize and differences
DeepRhythm Platform
Medicalgorithmics S.A.
DeepRhythm Platform05903021560698 —On the market

Similar devices

Other devices filed under FDA product code DPS (Electrocardiograph).

Other devices from Medicalgorithmics S.A.

See all devices from Medicalgorithmics S.A. →